Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2022-10-18 00:00:00 ET · period of report 2022-10-17 · accession 0000874015-22-000164 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-18 | 2022-10-17 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $0.00 | +416 | 14.2K | +3% | $0 |
| D | 2022-10-18 | 2022-10-17 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | F - Tax | $46.52 | -144 | 14.0K | -1% | -$6,699 |
| D | 2022-10-18 | 2022-10-17 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $0.00 | -416 | 35.9K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-17 | M | A | 416 | $0.00 | 14,176 | D | — | — | (F1) Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award. |
| 2 | Common | Common Stock | 2022-10-17 | F | D | 144 | $46.52 | 14,032 | D | — | — | (F2) Shares withheld to cover the required tax withholding obligations pursuant to the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. |
| 3 | Derivative | Restricted Stock Unit | 2022-10-17 | M | D | 416 | $0.00 | 35,909 | D | $0.00 · — to — | 416 Common Stock | (F3) Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value. (F4) Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. |